謝 屈平

Medicine & Life Sciences

1. dragon's blood 100%
2. Polygonum 90%
3. Streptozocin 53%
4. Thoracic Aorta 53%
5. Nitric Oxide Synthase 51%
6. Vasodilation 51%
7. Cell- and Tissue-Based Therapy 50%
8. Mesenchymal Stem Cells 48%
9. Ethanol 45%
10. Myocardium 44%
11. Endothelial Cells 39%
12. Stem Cells 39%
13. Myocardial Infarction 39%
14. Heart 34%
15. Cytokines 33%
16. Hydrogels 28%
17. Cell Lineage 28%
18. Biocompatible Materials 27%
19. Matrix Metalloproteinases 25%
20. Cardiac Myocytes 24%
21. Electric Stimulation 24%
22. In Vitro Techniques 23%
23. Oxygen 22%
24. Blood Platelets 20%
25. Cell Survival 20%
26. Guanosine Monophosphate 20%
27. Fibrosis 19%
28. Fibroblasts 19%
29. NF-E2-Related Factor 2 19%
30. Heme Oxygenase-1 15%
31. NG-Nitroarginine Methyl Ester 15%
32. Interleukin-1 13%
33. Therapeutics 11%
34. Guanylate Cyclase 11%
35. Blood Glucose 11%
36. Methylene Blue 10%
37. Phenylephrine 9%
38. Human Umbilical Vein Endothelial Cells 9%
39. Insulin 9%
40. Inbred ICR Mouse 8%
41. Blood Vessels 7%
42. Aorta 7%
43. Tibetan Traditional Medicine 7%
44. Hemoglobins 7%
45. Anti-Inflammatory Agents 6%
46. 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester 6%
47. Lipid Peroxidation 6%
48. Phosphorylation 6%
49. omega-N-Methylarginine 6%
50. Hyperglycemia 6%